Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 30/08/1988 - 01/02/1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 30/08/1988 - 01/02/1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- A discussion and report on the read across strategy is given as an attachment in IUCLID Section 13.
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: The test material did not induce structural chromosome aberrations.
- Additional information on results:
- Both sexes examined for all dose levels except for the top dose (5000 mg/kg bw) where only males were examined. Data on body weight, food intake and water intake obtained from the rats of the positive control group for the cytogenic study were essentially the same as those obtained in the negative controls
RESULTS OF DEFINITIVE STUDY
I] Chromosome Aberration Test:
No statistically significant differences in the number of bone marrow cells with structural chromosome aberrations were observed in any of the test groups when compared to the vehicle controls. The mitotic index obtained for the various groups did not show a dose-related difference from the vehicle control value while the positive control substance, mitomycin C, showed the expected statistically significant increase in the number of cells with structural chromosome aberrations. - Conclusions:
- There was no evidence that technical hexane induced structural chromosome aberrations in bone marrow cells of rats in vivo.
- Executive summary:
This data is being read across from the source study that tested technical hexane based on analogue read across.
In an in vivo chromosome aberration study,the test material (Technical hexane (hexane food grade) containing 58% n-hexane) was administered once daily to Wistar derived (Bor: WISW (SPF Cpb)) rats (10/sex/dose, except for the highest dose group where only males were examined) via oral gavage at doses of 0, 40, 200, 1000 or 5000 mg/kg/bw/day in soya bean oil for 13 weeks.The positive control group animals (5/sex) were treated once, 24 hrs prior to sacrifice, with 3.0 mg mitomycin C/kg bw. Two hours prior to sacrifice, all animals were weighed and injected with 8 mg colcemid/kg bw to accumulate metaphase cells. Animals were sacrificed via decapitation. Bone marrow cells obtained from the femur were fixed in 3:1 methanol and glacial acetic acid, spread on microscope slides, stained with 2% Giemsa solution and embedded in DePeX. Per animal, two slides were prepared and 50 metaphases containing 40-42 centromeres were examined. The slides were examined for chromatid- and chromosome-type aberrations and for other anomalies. Five hundred cells per slide were examined to determine the mitotic index. There was no evidence that technical hexane induced structural chromosome aberrations in bone marrow cells of rats in vivo.
Table 2. Summary of chromosome aberrations in bone marrow cells of male rats
Dose (per kg/bw) |
Harvest time (days) |
N1 |
n |
Number of cells with aberrations2 |
% cells with aberrations |
Mitotic Index3 |
||||
gaps |
breaks |
exchanges |
multiple |
Incl. gaps |
Excl. gaps |
|||||
Soya bean oil 10 mL/day |
90 |
500 |
10 |
13 |
4 |
0 |
0 |
3.4 |
0.8 |
2.3 |
Technical hexane 40 mg/day |
90 |
500 |
10 |
16 |
5 |
0 |
0 |
4.0 |
1.0 |
1.8 |
Technical hexane 200 mg/day |
90 |
400 |
8 |
10 |
4 |
0 |
0 |
3.5 |
1.0 |
2.0 |
Technical hexane 1000 mg/day |
90 |
500 |
10 |
13 |
5 |
0 |
0 |
3.2 |
1.0 |
1.8 |
Technical hexane 5000 mg/day |
90 |
350 |
7 |
12 |
9 |
0 |
0 |
5.1 |
2.6 |
1.9 |
Mitomycin C 3 mg |
1 |
250 |
5 |
32*** |
60*** |
27*** |
0 |
32.4*** |
28.8*** |
1.6 |
n = number of animals examined
Statistics: Fisher’s exact probability test (two-sided): * p<0.05; ** p<0.01; *** p<0.001
1. N = number of metaphases analysed (50 metaphases per animal)
2. gaps: include chromatid and isochromatid (chromosome) gaps; breaks: include chromatid and isochromatid (chromosome) breaks, interstitial deletions (minutes) and acentric fragments not associated with any obvious exchange process; exchanges: include chromatid and chromosome inter- and intrachanges; multiple aberrations: more than 10 aberrations (excl. gaps) per metaphase
3. mean percentage of metaphases determined in 1000 nuclei per animal
Table 3. Summary of chromosome aberrations in bone marrow cells of female rats
Dose (per kg/bw) |
Harvest time (days) |
N1 |
n |
Number of cells with aberrations2 |
% cells with aberrations |
Mitotic Index3 |
||||
gaps |
breaks |
exchanges |
multiple |
Incl. gaps |
Excl. gaps |
|||||
Soya bean oil 10 mL/day |
90 |
400 |
8 |
12 |
2 |
0 |
0 |
3.5 |
0.5 |
2.2 |
Technical hexane 40 mg/day |
90 |
500 |
10 |
18 |
4 |
0 |
0 |
4.2 |
0.8 |
2.0 |
Technical hexane 200 mg/day |
90 |
500 |
10 |
11 |
7 |
0 |
0 |
3.6 |
1.4 |
2.6 |
Technical hexane 1000 mg/day |
90 |
450 |
9 |
8 |
3 |
1 |
0 |
2.7 |
0.9 |
2.3 |
Mitomycin C 3 mg |
1 |
150 |
3 |
16 |
52*** |
19*** |
0 |
43.3*** |
40.7*** |
1.2 |
n = number of animals examined
Statistics: Fisher’s exact probability test (two-sided): * p<0.05; ** p<0.01; *** p<0.001
1. N = number of metaphases analysed (50 metaphases per animal)
2. gaps: include chromatid and isochromatid (chromosome) gaps; breaks: include chromatid and isochromatid (chromosome) breaks, interstitial deletions (minutes) and acentric fragments not associated with any obvious exchange process; exchanges: include chromatid and chromosome inter- and intrachanges; multiple aberrations: more than 10 aberrations (excl. gaps) per metaphase
3. mean percentage of metaphases determined in 1000 nuclei per animal
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- minor deviations from the protocol are not considered to have influenced the integrity or outcome of the study
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian bone marrow chromosome aberration test
Test material
- Reference substance name:
- N-hexane
- EC Number:
- 203-777-6
- EC Name:
- N-hexane
- Cas Number:
- 110-54-3
- Molecular formula:
- C6H14
- IUPAC Name:
- hexane
- Details on test material:
- - Analytical purity:
Technical grade
- Composition of test material, percentage of components:
n-hexane - 58%; benzene 0.060% weight (0.045% vol.)
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source: Shell, Amsterdam, The Netherlands
- Purity: n-hexane 58.0% weight; benzene 0.060% weight (0.045% vol.)
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Wistar derived, Bor:WISW (SPF Cpb)
- Details on species / strain selection:
- The rat was used because this species is considered the most suitable for this type of study and is usually required by regulatory agencies
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: F. Winkelmann, Institute for the Breeding of Laboratory Animals GmbH & Co. KG, Borchen, F.R.G.
- Age at study initiation: 3-4weeks upon arrival
- Weight at study initiation: 66.6 g (males)/ 63.0 g (females)
- Housing: groups of 5 separated by sex, in suspended, stainless steel cages fitted with wire screen bottom and front
- Diet (e.g. ad libitum): cereal-based open-formula stock diet provided ad libitum
- Water (e.g. ad libitum): tap water provided ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-24 °C
- Humidity (%): 50-70 %
- Air changes (per hr): 10 air changes/hr
- Photoperiod (hrs dark / hrs light): 12 hrs dark/ 12 hrs light
IN-LIFE DATES: From: 30 August 1988 To: 2 December 1988
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle used: soya oil
- Concentration of test material in vehicle: 0.4, 2, 10 or 50% (w/v)
- Amount of vehicle: 10 mL/kg body weight - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Solutions of the test substance in soybean oil containing 0.4, 2, 10 or 50% (w/ v) were freshly prepared once every week. The test solutions were stored in closed glass bottles in a refrigerator at about 5°C.
Each of the rats was given daily a single dose (10 ml/kg body weight) of the appropriate solution into the stomach by means of a syringe. The controls (groups A and F) received 10 ml soybean oil/kg body weight/day. The amount of test substance administered to each rat was adapted once a week to the change in body weight . - Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- Once daily, 7 days/week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- Control (Soybean Oil) - Group A
- Dose / conc.:
- 40 mg/kg bw/day (nominal)
- Remarks:
- Group B
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Remarks:
- Group C
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- Remarks:
- Group D
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- Remarks:
- Group E
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Remarks:
- Group F (Positive Control)
- No. of animals per sex per dose:
- 10/sex/dose based on number of surviving animals in each dose group (See Table 1)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- mitomycin C
- Route of administration: intraperitoneal injection
- Doses / concentrations: 3.0 mg/kg body weight (1 injection 24 hrs prior to sacrifice)
Examinations
- Tissues and cell types examined:
- Bone marrow cells from the femur
- Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
The number of surviving animals in each group of those designated for cytogenicity examination are given in Table 1. All these animals were used for metaphase chromosomal analysis. Group F group was added to the experiment, and used as a positive control in the cytogenetic study.
The rats of the positive control group were treated once, 24 hours prior to sacrifice, by intraperitoneal injection of 3.0 mg mitomycin C/ kg body weight to examine the sensitivity of the strain of rats used in this chromosome analysis test.
Two hours prior to sacrifice, the animals of the test groups and the positive and negative controls were weighed and then injected (i.p.) with 8 mg colcemid/kg body weight to accumulate metaphase cells. The animals were killed by decapitation. Then, the femurs were freed from adherent tissues. Bone marrow cells were removed from the femur by flushing with phosphate-buffered saline (pH 7.4), exposed to a hypotonic solution (0.075 M KCl) and fixed with 3:1 mixture of methanol and glacial acetic acid.
DETAILS OF SLIDE PREPARATION:
Cells were spread on microscope slides, stained with a 2% Giemsa (Merck, Darmstadt, F.R.G.) solution and embedded in DePeX. Two slides per animal were prepared for chromosome aberration analysis. The slides were randomized and coded to enable "blind" scoring.
METHOD OF ANALYSIS:
Per animal, 50 well-spread metaphases each containing 40-42 centromeres, were analysed for chromatid-type aberrations (gaps, breaks, fragments, interchanges) and chromosome-type aberrations (gaps, breaks, minutes, rings, dicentrics), and for other anomalies (endoreduplication, polyploid cells, heavily damaged cells). The Vernier readings of all metaphases scored were recorded. Five hundered cells per slide were examined to determine the percentage of cells in mitosis (mitotic index). - Evaluation criteria:
- A test substance producing neither a statistically significant dose-related increase in the number of cells with structural chromosome aberrations, nor a statistically significant and reproducible positive response at any of the doses was considered non-clastogenic in this system.
- Statistics:
- Chromosome Aberration test:
For statistical analysis of data aberration classes were combined into the general categories of chromatid- and chromosome type deletions (breaks), chromatid exchanges and chromosome exchanges. Data were analysed using Fisher's exact probability test.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Remarks on result:
- other: The test material did not induce structural chromosome aberrations.
- Additional information on results:
- Both sexes examined for all dose levels except for the top dose (5000 mg/kg bw) where only males were examined. Data on body weight, food intake and water intake obtained from the rats of the positive control group for the cytogenic study were essentially the same as those obtained in the negative controls
RESULTS OF DEFINITIVE STUDY
I] Chromosome Aberration Test:
No statistically significant differences in the number of bone marrow cells with structural chromosome aberrations were observed in any of the test groups when compared to the vehicle controls. The mitotic index obtained for the various groups did not show a dose-related difference from the vehicle control value while the positive control substance, mitomycin C, showed the expected statistically significant increase in the number of cells with structural chromosome aberrations.
Any other information on results incl. tables
Table 2. Summary of chromosome aberrations in bone marrow cells of male rats
Dose (per kg/bw) |
Harvest time (days) |
N1 |
n |
Number of cells with aberrations2 |
% cells with aberrations |
Mitotic Index3 |
||||
gaps |
breaks |
exchanges |
multiple |
Incl. gaps |
Excl. gaps |
|||||
Soya bean oil 10 mL/day |
90 |
500 |
10 |
13 |
4 |
0 |
0 |
3.4 |
0.8 |
2.3 |
Technical hexane 40 mg/day |
90 |
500 |
10 |
16 |
5 |
0 |
0 |
4.0 |
1.0 |
1.8 |
Technical hexane 200 mg/day |
90 |
400 |
8 |
10 |
4 |
0 |
0 |
3.5 |
1.0 |
2.0 |
Technical hexane 1000 mg/day |
90 |
500 |
10 |
13 |
5 |
0 |
0 |
3.2 |
1.0 |
1.8 |
Technical hexane 5000 mg/day |
90 |
350 |
7 |
12 |
9 |
0 |
0 |
5.1 |
2.6 |
1.9 |
Mitomycin C 3 mg |
1 |
250 |
5 |
32*** |
60*** |
27*** |
0 |
32.4*** |
28.8*** |
1.6 |
n = number of animals examined
Statistics: Fisher’s exact probability test (two-sided): * p<0.05; ** p<0.01; *** p<0.001
1. N = number of metaphases analysed (50 metaphases per animal)
2. gaps: include chromatid and isochromatid (chromosome) gaps; breaks: include chromatid and isochromatid (chromosome) breaks, interstitial deletions (minutes) and acentric fragments not associated with any obvious exchange process; exchanges: include chromatid and chromosome inter- and intrachanges; multiple aberrations: more than 10 aberrations (excl. gaps) per metaphase
3. mean percentage of metaphases determined in 1000 nuclei per animal
Table 3. Summary of chromosome aberrations in bone marrow cells of female rats
Dose (per kg/bw) |
Harvest time (days) |
N1 |
n |
Number of cells with aberrations2 |
% cells with aberrations |
Mitotic Index3 |
||||
gaps |
breaks |
exchanges |
multiple |
Incl. gaps |
Excl. gaps |
|||||
Soya bean oil 10 mL/day |
90 |
400 |
8 |
12 |
2 |
0 |
0 |
3.5 |
0.5 |
2.2 |
Technical hexane 40 mg/day |
90 |
500 |
10 |
18 |
4 |
0 |
0 |
4.2 |
0.8 |
2.0 |
Technical hexane 200 mg/day |
90 |
500 |
10 |
11 |
7 |
0 |
0 |
3.6 |
1.4 |
2.6 |
Technical hexane 1000 mg/day |
90 |
450 |
9 |
8 |
3 |
1 |
0 |
2.7 |
0.9 |
2.3 |
Mitomycin C 3 mg |
1 |
150 |
3 |
16 |
52*** |
19*** |
0 |
43.3*** |
40.7*** |
1.2 |
n = number of animals examined
Statistics: Fisher’s exact probability test (two-sided): * p<0.05; ** p<0.01; *** p<0.001
1. N = number of metaphases analysed (50 metaphases per animal)
2. gaps: include chromatid and isochromatid (chromosome) gaps; breaks: include chromatid and isochromatid (chromosome) breaks, interstitial deletions (minutes) and acentric fragments not associated with any obvious exchange process; exchanges: include chromatid and chromosome inter- and intrachanges; multiple aberrations: more than 10 aberrations (excl. gaps) per metaphase
3. mean percentage of metaphases determined in 1000 nuclei per animal
Applicant's summary and conclusion
- Conclusions:
- There was no evidence that technical hexane induced structural chromosome aberrations in bone marrow cells of rats in vivo.
- Executive summary:
In an in vivo chromosome aberration study,the test material (Technical hexane (hexane food grade) containing 58% n-hexane) was administered once daily to Wistar derived (Bor: WISW (SPF Cpb)) rats (10/sex/dose, except for the highest dose group where only males were examined) via oral gavage at doses of 0, 40, 200, 1000 or 5000 mg/kg/bw/day in soya bean oil for 13 weeks.The positive control group animals (5/sex) were treated once, 24 hrs prior to sacrifice, with 3.0 mg mitomycin C/kg bw. Two hours prior to sacrifice, all animals were weighed and injected with 8 mg colcemid/kg bw to accumulate metaphase cells. Animals were sacrificed via decapitation. Bone marrow cells obtained from the femur were fixed in 3:1 methanol and glacial acetic acid, spread on microscope slides, stained with 2% Giemsa solution and embedded in DePeX. Per animal, two slides were prepared and 50 metaphases containing 40-42 centromeres were examined. The slides were examined for chromatid- and chromosome-type aberrations and for other anomalies. Five hundred cells per slide were examined to determine the mitotic index. There was no evidence that technical hexane induced structural chromosome aberrations in bone marrow cells of rats in vivo.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
